Small-Molecule Targets in Tumor Immunotherapy.
Zhu, Hui-Fang; Li, Yan
Source PublicationNatural products and bioprospecting
AbstractCancer immunotherapy has been widely recognized as a powerful approach to fight cancers. To date, over 50 phase III trials in cancer immunotherapy are in progress. Among the many immunotherapy approaches, immune checkpoint therapy has attracted considerable attention. The reported clinical success of targeting the T cell immune checkpoint receptors PD-1 or CTLA4 by antibodies blockade in advanced stages of cancers has demonstrated the importance of immune modulation. But antibodies-based immunotherapy confronted with some disadvantages, such as immunogenicity, stability, membrane permeability, and production cost. Therefore, alternative approaches including small-molecule-regulated immune response are being introduced. In this review, we focused on some of the key intracellular pathways where small-molecule therapeutic is potential and attractive, which highlights the great potential of natural products in this field.
Document Type期刊论文
Recommended Citation
GB/T 7714
Zhu, Hui-Fang,Li, Yan. Small-Molecule Targets in Tumor Immunotherapy.[J]. Natural products and bioprospecting,2018,8(4):297-301.
APA Zhu, Hui-Fang,&Li, Yan.(2018).Small-Molecule Targets in Tumor Immunotherapy..Natural products and bioprospecting,8(4),297-301.
MLA Zhu, Hui-Fang,et al."Small-Molecule Targets in Tumor Immunotherapy.".Natural products and bioprospecting 8.4(2018):297-301.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Zhu, Hui-Fang]'s Articles
[Li, Yan]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zhu, Hui-Fang]'s Articles
[Li, Yan]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zhu, Hui-Fang]'s Articles
[Li, Yan]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.